HUANG MICHAEL F. (Sr. VP of Clinical Development) sold 28.4% of their position (14.58K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $1.01M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−371.00
Price / share
$65.97
Trade value
$24.47K
% of position
Common Stock
Shares
−604.00
Price / share
$66.79
Trade value
$40.34K
% of position
Common Stock
Shares
−1.10K
Price / share
$67.70
Trade value
$74.34K
% of position
Common Stock
Shares
−1.44K
Price / share
$68.79
Trade value
$99.33K
% of position
Common Stock
Shares
−836.00
Price / share
$69.84
Trade value
$58.38K
% of position
Common Stock
Shares
−86.00
Price / share
$70.73
Trade value
$6.08K
% of position
Common Stock
Shares
−125.00
Price / share
$71.74
Trade value
$8.97K
% of position
Common Stock
Shares
−19.00
Price / share
$72.64
Trade value
$1.38K
% of position
Common Stock
Shares
+10K
Price / share
$21.93
Trade value
$219.30K
% of position
Common Stock
Shares
−10K
Price / share
$70.03
Trade value
$700.33K
% of position
Net shares
−4.58K
Net value
-$794.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2025 | S · Sale | −371.00 | $65.97 | $24.47K | 0.9% | 41.40K | 41.03K |
| Common Stock Direct | 3/27/2025 | S · Sale | −604.00 | $66.79 | $40.34K | 1.5% | 41.03K | 40.42K |
| Common Stock Direct | 3/27/2025 | S · Sale | −1.10K | $67.70 | $74.34K | 2.7% | 40.42K | 39.33K |
| Common Stock Direct | 3/27/2025 | S · Sale | −1.44K | $68.79 | $99.33K | 3.7% | 39.33K | 37.88K |
| Common Stock Direct | 3/27/2025 | S · Sale | −836.00 | $69.84 | $58.38K | 2.2% | 37.88K | 37.05K |
| Common Stock Direct | 3/27/2025 | S · Sale | −86.00 | $70.73 | $6.08K | 0.2% | 37.05K | 36.96K |
| Common Stock Direct | 3/27/2025 | S · Sale | −125.00 | $71.74 | $8.97K | 0.3% | 36.96K | 36.84K |
| Common Stock Direct | 3/27/2025 | S · Sale | −19.00 | $72.64 | $1.38K | 0.1% | 36.84K | 36.82K |
| Common Stock Direct | 3/27/2025 | M · Option Exercise | +10K | $21.93 | $219.30K | 27.2% | 36.82K | 46.82K |
| Common Stock Direct | 3/27/2025 | S · Sale | −10K | $70.03 | $700.33K | 21.4% | 46.82K | 36.82K |
| Total | −4.58K | -$794.33K | ||||||
Employee stock option (right to buy)
Common Stock
10K shares
Shares
−10K
Strike price
21.93
Held after
110K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock10K shares | 3/27/2025 | M · Option Exercise | −10K | 21.93 | — | 110K |